SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2 )*
CYBERONICS, INC.
----------------
(Name of Issuer)
Common Stock, $0.01 par value
-----------------------------
(Title of Class of Securities)
23251P-10-2
-----------
(CUSIP Number)
Kevin T. O'Malley
Vice President and General Counsel
St. Jude Medical, Inc.
One Lillehei Plaza
St. Paul, Minnesota 55117
Telephone: (651) 483-2000
--------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 9, 1998
--------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box.|_|
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 3 Pages
<PAGE>
CUSIP No. 23251P-10-2
- -----------------------
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
St. Jude Medical, Inc.
41-1276891
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See instructions) N/A
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION MINNESOTA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 1,501,818
SHARES -------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER -0-
OWNED BY -------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 1,501,818
REPORTING
-------------------------------------------------------
PERSON
10 SHARED DISPOSITIVE POWER -0-
WITH:
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,501,818
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
instructions) [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.58%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See instructions) CO
- --------------------------------------------------------------------------------
Page 2 of 3 Pages
<PAGE>
Item 5. Interest in Securities of the Issuer
(c) The purpose of this filing is to report four sales by St. Jude
Medical, Inc. of an aggregate 680,000 shares of Common Stock of Cyberonics, Inc.
("Cyberonics") in April 1998. The sales were effected in open market
transactions. Cyberonics' shares are traded on the Nasdaq National Market. As a
result of the sales, the remaining 1,501,818 shares beneficially owned by St.
Jude Medical, Inc. represent approximately 8.58% of the currently outstanding
shares of Common Stock of Cyberonics. St. Jude Medical, Inc. has sole voting and
dispositive power with respect to all of the shares of Common Stock of
Cyberonics that it owns. Set forth below are the respective sales of Common
Stock of Cyberonics made by St. Jude Medical, Inc. in April 1998:
Date No. of Shares Sold Price Per Share
---- ------------------ ---------------
04/09/98 600,000 $ 29.375
04/14/98 55,000 31.00
04/14/98 15,000 30.875
04/15/98 10,000 31.00
-------
Total: 680,000
Remaining
Shares Held: 1,501,818 (8.58%)
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: February 25, 1999. ST. JUDE MEDICAL, INC.
By /s/ Kevin T. O'Malley
--------------------------------------
Kevin T. O'Malley
Vice President and General Counsel
Page 3 of 3 Pages
